Fresenius Medical Care AG (FMS)
20.97
-0.69
(-3.19%)
USD |
NYSE |
May 03, 16:00
21.05
+0.08
(+0.38%)
After-Hours: 20:00
Fresenius Medical Care Revenue (TTM): 21.06B for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 21.06B |
| September 30, 2023 | 20.80B |
| June 30, 2023 | 20.56B |
| March 31, 2023 | 20.36B |
| December 31, 2022 | 20.41B |
| September 30, 2022 | 20.62B |
| June 30, 2022 | 20.72B |
| March 31, 2022 | 20.86B |
| December 31, 2021 | 20.83B |
| September 30, 2021 | 20.76B |
| June 30, 2021 | 20.69B |
| March 31, 2021 | 20.50B |
| December 31, 2020 | 20.38B |
| September 30, 2020 | 20.20B |
| June 30, 2020 | 19.96B |
| March 31, 2020 | 19.82B |
| December 31, 2019 | 19.56B |
| September 30, 2019 | 19.39B |
| June 30, 2019 | 19.20B |
| March 31, 2019 | 19.35B |
| December 31, 2018 | 19.54B |
| September 30, 2018 | 19.85B |
| June 30, 2018 | 20.23B |
| March 31, 2018 | 20.12B |
| December 31, 2017 | 20.08B |
| Date | Value |
|---|---|
| September 30, 2017 | 19.63B |
| June 30, 2017 | 19.23B |
| March 31, 2017 | 18.86B |
| December 31, 2016 | 18.33B |
| September 30, 2016 | 18.43B |
| June 30, 2016 | 17.91B |
| March 31, 2016 | 17.50B |
| December 31, 2015 | 17.30B |
| September 30, 2015 | 17.37B |
| June 30, 2015 | 17.49B |
| March 31, 2015 | 17.21B |
| December 31, 2014 | 16.63B |
| September 30, 2014 | 15.27B |
| June 30, 2014 | 14.57B |
| March 31, 2014 | 14.34B |
| December 31, 2013 | 14.36B |
| September 30, 2013 | 14.14B |
| June 30, 2013 | 13.86B |
| March 31, 2013 | 13.71B |
| December 31, 2012 | 13.34B |
| September 30, 2012 | 13.83B |
| June 30, 2012 | 13.82B |
| March 31, 2012 | 13.47B |
| December 31, 2011 | 13.16B |
| September 30, 2011 | 12.56B |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
19.20B
Minimum
Jun 2019
21.06B
Maximum
Dec 2023
20.35B
Average
20.50B
Median
Mar 2021
Revenue (TTM) Benchmarks
| Biodexa Pharmaceuticals Plc | 0.4761M |
| NuCana PLC | -- |
| TC BioPharm (Holdings) PLC | -- |
| DaVita Inc | 12.34B |
| Bicycle Therapeutics PLC | 26.98M |